|
E-Lovu signs first 3 year commercial agreement
|
15 June 2023 at 10:00am
|
|
Further information - Strategic Partnership Rewards Platform
|
6 June 2023 at 2:25pm
|
|
Trading Halt
|
5 June 2023 at 10:10am
|
|
Strategic Partnership signed - US employee rewards platform
|
1 June 2023 at 9:05am
|
|
Results of Annual General Meeting
|
30 May 2023 at 6:35pm
|
|
Contract signed with private Obstetrics & Gynaecology Group
|
11 May 2023 at 10:45am
|
|
Notice of Annual General Meeting/Proxy Form
|
28 April 2023 at 4:30pm
|
|
Quarterly Activities & Cashflow Report
|
28 April 2023 at 10:20am
|
|
Final Director's Interest Notice
|
24 April 2023 at 1:10pm
|
|
Board & Management changes
|
20 April 2023 at 9:50am
|
|
Date of AGM and Closing Date for Director Nominations
|
14 April 2023 at 5:35pm
|
|
Change of Director's Interest Notice
|
27 March 2023 at 1:10pm
|
|
Appendix 4G and Corporate Governance Statement
|
23 March 2023 at 8:40am
|
|
Annual Report to shareholders
|
23 March 2023 at 8:40am
|
|
Gold Coast Hospital to begin trial of the HeraCARE Platform
|
21 March 2023 at 10:05am
|
|
Appendix 2A
|
1 March 2023 at 6:15pm
|
|
Cleansing Prospectus
|
1 March 2023 at 2:50pm
|
|
Proposed issue of securities - HMD
|
1 March 2023 at 2:50pm
|
|
Appendix 4E & Preliminary Final Report
|
28 February 2023 at 2:15pm
|
|
Successful First Phase - e-Lovu Initial Commercial Rollout
|
20 February 2023 at 9:30am
|
|
Distribution Schedule
|
8 February 2023 at 4:15pm
|
|
Top 20 securityholders
|
8 February 2023 at 4:15pm
|
|
Results of Meeting
|
2 February 2023 at 5:20pm
|
|
Quarterly Activities & Cashflow Report
|
31 January 2023 at 10:20am
|
|
Notification regarding unquoted securities - HMD
|
27 January 2023 at 3:55pm
|
|
Appointment of Keith Koby as President, North America
|
24 January 2023 at 9:05am
|
|
HMD - Securities Trading Policy
|
23 January 2023 at 12:10pm
|
|
Correction - Notice of General Meeting
|
16 January 2023 at 7:05pm
|
|
Notice of General Meeting
|
29 December 2022 at 4:35pm
|
|
Ramsay Affiliated Melbourne Mothers Practice Adopts HeraCARE
|
23 November 2022 at 8:55am
|
|
JHCs Clinical Trial Published in Nature Portfolio
|
8 November 2022 at 8:55am
|
|
Quarterly Activities & Cashflow Report
|
28 October 2022 at 11:50am
|
|
Notification regarding unquoted securities - HMD
|
25 October 2022 at 12:50pm
|
|
Notification regarding unquoted securities - HMD
|
25 October 2022 at 12:40pm
|
|
Notification regarding unquoted securities - HMD
|
25 October 2022 at 12:30pm
|
|
Cleansing Notice
|
25 October 2022 at 11:40am
|
|
Application for quotation of securities - HMD
|
25 October 2022 at 11:35am
|
|
Results of Annual General Meeting
|
12 October 2022 at 2:30pm
|
|
Initial Director's Interest Notice - Emily Slade
|
13 September 2022 at 6:10pm
|
|
Appointment of Emily Slade as a Non-Executive Director
|
13 September 2022 at 10:05am
|
|
Notice of Annual General Meeting/Proxy Form
|
9 September 2022 at 5:30pm
|
|
Cleansing Notice
|
31 August 2022 at 5:35pm
|
|
Application for quotation of securities - HMD
|
31 August 2022 at 5:30pm
|
|
Appendix 4D and Half Year Report
|
26 August 2022 at 5:30pm
|
|
Proposed issue of securities - HMD
|
24 August 2022 at 10:20am
|
|
HeraMED Completes $4 Million Private Placement
|
24 August 2022 at 10:20am
|
|
Trading Halt
|
22 August 2022 at 9:45am
|
|
Notification of cessation of securities - HMD
|
18 August 2022 at 5:40pm
|
|
Notification of cessation of securities - HMD
|
16 August 2022 at 6:15pm
|
|
Notification regarding unquoted securities - HMD
|
2 August 2022 at 6:15pm
|
HeraMED